Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Cereda

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Cancer Chemotherapy and Pharmacology|December 15, 2015
Capecitabine with/without mitomycin C: results of a randomized phase II trial of second-line therapy in advanced biliary tract adenocarcinomaS Cereda, M Milella, S Cordio, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 27, 2007
Development and pharmacological evaluation of ropivacaine-2-hydroxypropyl-beta-cyclodextrin inclusion complexDaniele R de Araujo, Simone S Tsuneda, Cíntia M S Cereda, et al.
Scientific Reports|August 3, 2019
Improved efficacy of naproxen-loaded NLC for temporomandibular joint administrationViviane A Guilherme, Lígia N M Ribeiro, Ana C S Alcântara, et al.
Journal of Bone Oncology|July 26, 2018
Bone metastases in biliary cancers: A multicenter retrospective surveyD Santini, G Brandi, G Aprile, et al.
British Journal of Cancer|April 10, 2014
Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancerL Fornaro, S Cereda, G Aprile, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Cancer Chemotherapy and Pharmacology|December 15, 2015
Capecitabine with/without mitomycin C: results of a randomized phase II trial of second-line therapy in advanced biliary tract adenocarcinomaS Cereda, M Milella, S Cordio, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 27, 2007
Development and pharmacological evaluation of ropivacaine-2-hydroxypropyl-beta-cyclodextrin inclusion complexDaniele R de Araujo, Simone S Tsuneda, Cíntia M S Cereda, et al.
Scientific Reports|August 3, 2019
Improved efficacy of naproxen-loaded NLC for temporomandibular joint administrationViviane A Guilherme, Lígia N M Ribeiro, Ana C S Alcântara, et al.
Journal of Bone Oncology|July 26, 2018
Bone metastases in biliary cancers: A multicenter retrospective surveyD Santini, G Brandi, G Aprile, et al.
British Journal of Cancer|April 10, 2014
Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancerL Fornaro, S Cereda, G Aprile, et al.
Pageof 3